Patents by Inventor Gary Hayter

Gary Hayter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240374173
    Abstract: Methods, devices, and systems may use a kinetic model to determine physiological parameters related to the kinetics of red blood cell glycation, elimination, and generation. Such physiological parameters can be used, for example, to determine a more reliable calculated HbA1c. In another example, a method may comprise: receiving a plurality of glucose levels over a time period; receiving a glycated hemoglobin (HbA1c) level corresponding to an end of the time period; determining at least one physiological parameter selected from the group consisting of: a red blood cell glycation rate constant (kgly), a red blood cell generation rate constant (kgen), a red blood cell elimination constant (kage), and an apparent glycation constant (K), based on (1) the plurality of glucose levels and (2) the HbA1c level; and adjusting a glucose level target based on the at least one physiological parameter.
    Type: Application
    Filed: July 22, 2024
    Publication date: November 14, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Yongjin Xu, Timothy C. Dunn, Gary Hayter
  • Patent number: 12042276
    Abstract: Methods, devices, and systems may use a kinetic model to determine physiological parameters related to the kinetics of red blood cell glycation, elimination, and generation. Such physiological parameters can be used, for example, to determine a more reliable calculated HbA1c. In another example, a method may comprise: receiving a plurality of glucose levels over a time period; receiving a glycated hemoglobin (HbA1c) level corresponding to an end of the time period; determining at least one physiological parameter selected from the group consisting of: a red blood cell glycation rate constant (kgly), a red blood cell generation rate constant (kgen), a red blood cell elimination constant (kage), and an apparent glycation constant (K), based on (1) the plurality of glucose levels and (2) the HbA1c level; and adjusting a glucose level target based on the at least one physiological parameter.
    Type: Grant
    Filed: August 8, 2022
    Date of Patent: July 23, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Yongjin Xu, Timothy C. Dunn, Gary Hayter
  • Publication number: 20230263955
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting a signal level associated with the monitored physiological condition deviating from a predetermined threshold level, retrieving the medication level administered associated with a time period of the detected signal level, applying the retrieved medication level to the detected signal based on a predefined predictive model to generate a predictive signal, and comparing the detected signal to the predictive signal to determine whether a condition associated with the detected signal level is present are provided.
    Type: Application
    Filed: May 2, 2023
    Publication date: August 24, 2023
    Inventors: Gary HAYTER, Erwin S. BUDIMAN
  • Patent number: 11679200
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting a signal level associated with the monitored physiological condition deviating from a predetermined threshold level, retrieving the medication level administered associated with a time period of the detected signal level, applying the retrieved medication level to the detected signal based on a predefined predictive model to generate a predictive signal, and comparing the detected signal to the predictive signal to determine whether a condition associated with the detected signal level is present are provided.
    Type: Grant
    Filed: January 21, 2019
    Date of Patent: June 20, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Hayter, Erwin S. Budiman
  • Publication number: 20230024262
    Abstract: Methods, devices, and systems may use a kinetic model to determine physiological parameters related to the kinetics of red blood cell glycation, elimination, and generation. Such physiological parameters can be used, for example, to determine a more reliable calculated HbA1c. In another example, a method may comprise: receiving a plurality of glucose levels over a time period; receiving a glycated hemoglobin (HbA1c) level corresponding to an end of the time period; determining at least one physiological parameter selected from the group consisting of: a red blood cell glycation rate constant (kgly), a red blood cell generation rate constant (kgen), a red blood cell elimination constant (kage), and an apparent glycation constant (K), based on (1) the plurality of glucose levels and (2) the HbA1c level; and adjusting a glucose level target based on the at least one physiological parameter.
    Type: Application
    Filed: August 8, 2022
    Publication date: January 26, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Yongjin Xu, Timothy C. Dunn, Gary Hayter
  • Patent number: 11406293
    Abstract: Methods, devices, and systems may use a kinetic model to determine physiological parameters related to the kinetics of red blood cell glycation, elimination, and generation. Such physiological parameters can be used, for example, to determine a more reliable calculated HbA1c. In another example, a method may comprise: receiving a plurality of glucose levels over a time period; receiving a glycated hemoglobin (HbA1c) level corresponding to an end of the time period; determining at least one physiological parameter selected from the group consisting of: a red blood cell glycation rate constant (kgly), a red blood cell generation rate constant (kgen), a red blood cell elimination constant (kage), and an apparent glycation constant (K), based on (1) the plurality of glucose levels and (2) the HbA1c level; and adjusting a glucose level target based on the at least one physiological parameter.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: August 9, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Yongjin Xu, Timothy C. Dunn, Gary Hayter
  • Patent number: 10406286
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting an impending administration of the medication level exceeding a predetermined threshold level, retrieving one or more signals associated with the monitored physiological condition, determining an accuracy indication of the retrieved one or more signals associated with the monitored physiological condition, and executing the administration of the medication level based on the accuracy indication are provided.
    Type: Grant
    Filed: April 16, 2018
    Date of Patent: September 10, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Gary Hayter
  • Publication number: 20190151542
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting a signal level associated with the monitored physiological condition deviating from a predetermined threshold level, retrieving the medication level administered associated with a time period of the detected signal level, applying the retrieved medication level to the detected signal based on a predefined predictive model to generate a predictive signal, and comparing the detected signal to the predictive signal to determine whether a condition associated with the detected signal level is present are provided.
    Type: Application
    Filed: January 21, 2019
    Publication date: May 23, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary Hayter, Erwin S. Budiman
  • Patent number: 10188794
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting a signal level associated with the monitored physiological condition deviating from a predetermined threshold level, retrieving the medication level administered associated with a time period of the detected signal level, applying the retrieved medication level to the detected signal based on a predefined predictive model to generate a predictive signal, and comparing the detected signal to the predictive signal to determine whether a condition associated with the detected signal level is present are provided.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: January 29, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary Hayter, Erwin S. Budiman
  • Patent number: 10111608
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: October 30, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Gary Hayter
  • Publication number: 20180296140
    Abstract: Generally, methods, devices, and systems for generating a hybrid analyte level output are provided. The uncompensated analyte levels lag in time with respect to the lag-compensated analyte levels, and the hybrid analyte level output tracks between the uncompensated analyte levels and the lag-compensated analyte levels according to predetermined criteria.
    Type: Application
    Filed: June 21, 2018
    Publication date: October 18, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventor: Gary Hayter
  • Publication number: 20180296758
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting an impending administration of the medication level exceeding a predetermined threshold level, retrieving one or more signals associated with the monitored physiological condition, determining an accuracy indication of the retrieved one or more signals associated with the monitored physiological condition, and executing the administration of the medication level based on the accuracy indication are provided.
    Type: Application
    Filed: April 16, 2018
    Publication date: October 18, 2018
    Inventor: Gary Hayter
  • Publication number: 20180235524
    Abstract: Methods, devices, and systems may use a kinetic model to determine physiological parameters related to the kinetics of red blood cell glycation, elimination, and generation. Such physiological parameters can be used, for example, to determine a more reliable calculated HbA1c. In another example, a method may comprise: receiving a plurality of glucose levels over a time period; receiving a glycated hemoglobin (HbA1c) level corresponding to an end of the time period; determining at least one physiological parameter selected from the group consisting of: a red blood cell glycation rate constant (kgly), a red blood cell generation rate constant (kgen), a red blood cell elimination constant (kage), and an apparent glycation constant (K), based on (1) the plurality of glucose levels and (2) the HbA1c level; and adjusting a glucose level target based on the at least one physiological parameter.
    Type: Application
    Filed: February 21, 2018
    Publication date: August 23, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Timothy C. Dunn, Yongjin Xu, Gary Hayter
  • Publication number: 20180199813
    Abstract: Systems, devices, and methods are provided that allow the monitoring of analyte levels within analyte monitoring systems. The analyte monitoring systems can be in vivo systems and can include a sensor control device with a sensor and accompanying circuitry, as well as a relay device for communicating with the sensor control device and a reader device.
    Type: Application
    Filed: March 7, 2018
    Publication date: July 19, 2018
    Inventors: Michael R. Love, Jeffery M. Sicurello, Gary Hayter, Xuandong Hua, Mark Sloan, John Dinh, Glenn Berman
  • Patent number: 10002233
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: May 14, 2008
    Date of Patent: June 19, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Hayter, Lei He, Mark K. Sloan, Benjamin J. Feldman
  • Patent number: 9949642
    Abstract: Systems, devices, and methods are provided that allow the monitoring of analyte levels within analyte monitoring systems. The analyte monitoring systems can be in vivo systems and can include a sensor control device with a sensor and accompanying circuitry, as well as a relay device for communicating with the sensor control device and a reader device.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: April 24, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Michael R. Love, Jeffery M. Sicurello, Gary Hayter, Xuandong Hua, Mark Sloan, John Dinh, Glenn Berman
  • Patent number: 9943644
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting an impending administration of the medication level exceeding a predetermined threshold level, retrieving one or more signals associated with the monitored physiological condition, determining an accuracy indication of the retrieved one or more signals associated with the monitored physiological condition, and executing the administration of the medication level based on the accuracy indication are provided.
    Type: Grant
    Filed: August 31, 2008
    Date of Patent: April 17, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Gary Hayter
  • Patent number: 9615780
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: April 11, 2017
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Gary Hayter
  • Publication number: 20160331232
    Abstract: Systems, devices, and methods are provided that allow the monitoring of analyte levels within analyte monitoring systems. The analyte monitoring systems can be in vivo systems and can include a sensor control device with a sensor and accompanying circuitry, as well as a relay device for communicating with the sensor control device and a reader device.
    Type: Application
    Filed: May 13, 2016
    Publication date: November 17, 2016
    Inventors: Michael R. Love, Jeffery M. Sicurello, Gary Hayter, Xuandong Hua, Mark Sloan, John Dinh, Glenn Berman
  • Publication number: 20160296697
    Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting a signal level associated with the monitored physiological condition deviating from a predetermined threshold level, retrieving the medication level administered associated with a time period of the detected signal level, applying the retrieved medication level to the detected signal based on a predefined predictive model to generate a predictive signal, and comparing the detected signal to the predictive signal to determine whether a condition associated with the detected signal level is present are provided.
    Type: Application
    Filed: June 16, 2016
    Publication date: October 13, 2016
    Inventors: Gary Hayter, Erwin S. Budiman